Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N H Mulder

Showing results (231-240 of 369) with videos related to

Pageof 37
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1994
High dose oral amiodarone added to doxorubicin and vindesine for overcoming multidrug resistance in solid tumorsW T van der Graaf, J Buter, E G de Vries, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|November 1, 1994
Hyperthermic potentiation of cisplatin toxicity in a human small cell lung carcinoma cell line and a cisplatin resistant sublineJ V Hettinga, W Lemstra, C Meijer, et al.
American Journal of Respiratory and Critical Care Medicine|December 1, 1995
Pulmonary function changes in lung-cancer patients treated with radiation with or without carboplatinH J Groen, T W van der Mark, A H van der Leest, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|November 4, 2004
Developments in treatment of primary irresectable rectal cancerO Reerink, N H Mulder, B G Szabo, et al.
Lancet (London, England)|June 23, 1990
Low-dose regimen of interleukin-2 for metastatic renal carcinomaD T Sleijfer, R A Janssen, P H Willemse, et al.
British Journal of Cancer|January 1, 1997
A quantitative reverse transcriptase polymerase chain reaction-based assay to detect carcinoma cells in peripheral bloodW Helfrich, R ten Poele, G J Meersma, et al.
European Journal of Cancer (Oxford, England : 1990)|March 1, 1990
Risks and benefits of cisplatin in ovarian cancer. A quality-adjusted survival analysisP H Willemse, J van Lith, N H Mulder, et al.
British Journal of Cancer|August 1, 1996
Selection of a subpopulation with fewer DNA topoisomerase II alpha gene copies in a doxorubicin-resistant cell line panelS Withoff, W N Keith, A J Knol, et al.
International Journal of Cancer|September 9, 1993
Evaluation of S9788 as a potential modulator of drug resistance against human tumour sublines expressing differing resistance mechanisms in vitroB T Hill, W T van der Graaf, L K Hosking, et al.
British Journal of Cancer|October 1, 1994
Dacarbazine (DTIC)-based chemotherapy or chemoimmunotherapy of patients with disseminated malignant melanomaN H Mulder, W T van der Graaf, P H Willemse, et al.
Pageof 37

Showing results (231-240 of 369) with videos related to

Sort By:
Pageof 37
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1994
High dose oral amiodarone added to doxorubicin and vindesine for overcoming multidrug resistance in solid tumorsW T van der Graaf, J Buter, E G de Vries, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|November 1, 1994
Hyperthermic potentiation of cisplatin toxicity in a human small cell lung carcinoma cell line and a cisplatin resistant sublineJ V Hettinga, W Lemstra, C Meijer, et al.
American Journal of Respiratory and Critical Care Medicine|December 1, 1995
Pulmonary function changes in lung-cancer patients treated with radiation with or without carboplatinH J Groen, T W van der Mark, A H van der Leest, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|November 4, 2004
Developments in treatment of primary irresectable rectal cancerO Reerink, N H Mulder, B G Szabo, et al.
Lancet (London, England)|June 23, 1990
Low-dose regimen of interleukin-2 for metastatic renal carcinomaD T Sleijfer, R A Janssen, P H Willemse, et al.
British Journal of Cancer|January 1, 1997
A quantitative reverse transcriptase polymerase chain reaction-based assay to detect carcinoma cells in peripheral bloodW Helfrich, R ten Poele, G J Meersma, et al.
European Journal of Cancer (Oxford, England : 1990)|March 1, 1990
Risks and benefits of cisplatin in ovarian cancer. A quality-adjusted survival analysisP H Willemse, J van Lith, N H Mulder, et al.
British Journal of Cancer|August 1, 1996
Selection of a subpopulation with fewer DNA topoisomerase II alpha gene copies in a doxorubicin-resistant cell line panelS Withoff, W N Keith, A J Knol, et al.
International Journal of Cancer|September 9, 1993
Evaluation of S9788 as a potential modulator of drug resistance against human tumour sublines expressing differing resistance mechanisms in vitroB T Hill, W T van der Graaf, L K Hosking, et al.
British Journal of Cancer|October 1, 1994
Dacarbazine (DTIC)-based chemotherapy or chemoimmunotherapy of patients with disseminated malignant melanomaN H Mulder, W T van der Graaf, P H Willemse, et al.
Pageof 37